VaxGen Inc. Fighting the AIDS Epidemic Harvard Case Solution & Analysis

Details efforts VaxGen and its president, Don Francis, to obtain permission to conduct a Phase III clinical trial in Thailand AIDSVAX, an experimental vaccine designed to protect against the human immunodeficiency virus (HIV), the virus that causes AIDS. Francis must struggle with a lot of ethical questions on how certain he should be on the effectiveness of AIDSVAX, to ensure the participation of thousands of subjects in clinical trials, to any type of compensation or treatment, if any, to offer volunteer subjects in developing countries, where standard for the treatment of AIDS are significantly lower than in the United States. "Hide
by Margaret L. Eaton, Jennifer Wilds, Betty Pang Source: Stanford Graduate School of Business 23 pages. Publication Date: February 15, 2005. Prod. #: BME1-PDF-ENG

Share This

SALE SALE

Save Up To

30%

IN ONLINE CASE STUDY

FOR FREE CASES AND PROJECTS INCLUDING EXCITING DEALS PLEASE REGISTER YOURSELF !!

Register now and save up to 30%.